Table 2.
The laboratory findings and imaging features of respiratory virus-infected patients.
| Flu A virus (n = 72) | Flu B virus (n = 32) | COVID-19 (n = 18) | RSV (n = 14) |
|
|---|---|---|---|---|
| White blood cell count, ×10⁹/L | 6.44 ± 2.23 | 5.44 ± 2.36 | 5.02 ± 1.62 | 11.49 ± 5.93 |
| Neutrophil count, ×10⁹/L | 4.91 ± 2.25 | 3.87 ± 2.19 | 2.70(1.95-3.25) | 8.03(4.33-11.73) |
| Lymphocyte count, ×10⁹/L | 0.81(0.50-1.41) | 1.01 ± 0.44 | 1.61 ± 0.65 | 1.80 ± 1.06 |
| Hemoglobin, g/L | 136.59 ± 21.04 | 145.20 ± 24.19 | 143.56 ± 21.69 | 117.00 ± 31.54 |
| Platelet count, ×10⁹/L | 196.00 ± 57.59 | 193.00 ± 49.29 | 214.67 ± 60.40 | 222.64 ± 122.11 |
| C-reactive protein, mg/L | 15.50(3.57-58.21) | 6.02(2.58-20.75) | 10.30(0.92-21.52) | 36.73(11.61-99.55) |
| Pneumonia in chest CT | 15/31 (48.39%) | 2/14 (14.29%) | 15/18 (83.33%) | 9/14 (64.29%) |
| Solitary lesion | 2 (13.33%) | 0 | 4 (26.67%) | 0 |
| Multiple lesion | 13 (86.67%) | 2 (100%) | 11 (73.33%) | 9 (100%) |
| Consolidation | 1 (6.67%) | 0 | 1 (6.67%) | 1 (11.11%) |
| Ground-glass opacity | 14 (93.33%) | 2 (100%) | 14 (93.33%) | 8 (88.89%) |
Notes: Flu A: influenza A; Flu B: influenza B; COVID-19: coronavirus disease, 2019; RSV: respiratory syncytial virus.